Skip to content

Clinical trials

Hypertension, Pulmonary trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Belgium Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20031
20041
20052
20062
20071
20083
20096
20103
20146
20152
20164
20171
20183
20193
20202
20216
20222
20232
20243
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated10
Recruiting7
Active, not recruiting6
Unknown status3
Enrolling by invitation2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer10
United Therapeutics7
Actelion5
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5
Insmed Incorporated3
Merck Sharp & Dohme LLC3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Bellerophon2
Biogen2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary64
Pulmonary Arterial Hypertension24
Lung Diseases, Interstitial5
Cardiovascular Diseases3
Familial Primary Pulmonary Hypertension3
Hypertension3
Lung Diseases3
Pulmonary Disease, Chronic Obstructive3
Vascular Diseases3
Connective Tissue Diseases2

Trials

Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.